Skip to main navigation Skip to search Skip to main content

In vivo repression of an erythroid-specific gene by distinct corepressor complexes

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)

Abstract

To assess the mechanisms of repression of the erythroid-specific carbonic anhydrase II (CAII) locus we used chromatin immunoprecipitation and show that an NCoR-histone deacetylase (HDAC)3 complex is recruited by the nuclear receptor v-ErbA to the intronic HS2 enhancer turning it into a potent silencer. Furthermore we demonstrate that efficient CAII silencing requires binding of a MeCP2-targeted HDAC-containing corepressor complex to the hypermethylated CpG-island at the promoter. Activation of transcription by either AZAdC or thyroid hormone results in loss of one of the two corepressor complexes. Thyroid hormone further replaces the enhancer-bound NCoR-corepressor complex by the TRAP220 coactivator. Treatment with the HDAC inhibitor trichostatin A (TSA) causes activation of CAII transcription and histone H3 and H4 hyperacetylation at the enhancer, apparently without affecting binding of the two corepressor complexes. Unexpectedly, histone H3 and H4 at the fully repressed promoter are already hyperacetylated despite the close apposition of the MeCP2-targeted HDAC complex. Acetylation of histone H4, but not H3, at the promoter is moderately increased following TSA treatment. Our data suggest that the hyperacetylated but repressed CAII promoter is (partially) remodeled and primed for activation in v-ErbA-transformed cells.

Original languageEnglish
Pages (from-to)1389-1397
Number of pages9
JournalEMBO Journal
Volume21
Issue number6
DOIs
Publication statusPublished - 15 Mar 2002
Externally publishedYes

Keywords

  • Corepressor
  • Erythroleukemia
  • HDAC
  • Methylation
  • v-ErbA

Fingerprint

Dive into the research topics of 'In vivo repression of an erythroid-specific gene by distinct corepressor complexes'. Together they form a unique fingerprint.

Cite this